Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hui-Xue Zeng"'
Autor:
Zhi‐Wei Huang, Hui‐Xue Zeng, Ya‐Ping Huang, Tie‐Zhu Wang, Wen‐Sen Huang, Yan‐Fei Huang, Li Lin, Hao Li
Publikováno v:
Brain and Behavior, Vol 13, Iss 4, Pp n/a-n/a (2023)
Abstract Background Alzheimer's disease (AD) is an irreversible, progressive brain disorder that impairs memory, thinking, language, and, eventually, the ability to carry out the simplest of tasks. Tau protein, the major component of neurofibrillary
Externí odkaz:
https://doaj.org/article/d7abe06f394a4433a6357766a4ebbcbe
Autor:
Li-Da Chen, Jie-Feng Huang, Qing-Shi Chen, Guo-Fu Lin, Hui-Xue Zeng, Xiao-Fen Lin, Xue-Jun Lin, Li Lin, Qi-Chang Lin, Li-Min Chen
Publikováno v:
Chinese Medical Journal, Vol 132, Iss 22, Pp 2670-2676 (2019)
Abstract. Background:. Obstructive sleep apnea hypopnea syndrome (OSAHS) is a contributing factor for non-alcoholic fatty liver disease (NAFLD). Non-invasive algorithms including fatty liver index (FLI) and hepatic steatosis index (HSI) have been use
Externí odkaz:
https://doaj.org/article/125f46fe3fd14fc789c20f5709d97e7b
Publikováno v:
Medicine; 4/26/2024, Vol. 103 Issue 17, p1-5, 5p
Autor:
Qin Chen, Qichang Lin, Miao-Fen Hu, Li-Da Chen, Yi-Feng Zheng, Meng-Xue Chen, Yan-Hua Wu, Wei-Liang Zhang, Hui-Xue Zeng
Publikováno v:
Sleep and Breathing. 24:1407-1415
Obstructive sleep apnea (OSA) has been demonstrated to be associated with an increase of oxidative stress. However, whether circulating malondialdehyde (MDA), a widely used biomarker of oxidative stress, could be reduced by the treatment of OSA by co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1625af6b83e88fcd24d6db9f1dbb79c4
https://doi.org/10.1007/s11325-019-01998-x
https://doi.org/10.1007/s11325-019-01998-x
Autor:
Yuming Ye, Yi-Feng Zheng, Hao Li, Qiyin Wu, Tiezhu Wang, Ya-Ping Huang, Li-Da Chen, Liang-Ji Zhang, Jia-Chao Qi, Qiao-Zhen Xu, Hui-Xue Zeng, Li Lin
Publikováno v:
Sleep and Breathing. 23:5-12
Cumulative evidence supports the clear relationship of obstructive sleep apnea (OSA) with cardiovascular disease (CVD). And, adherence to continuous positive airway pressure (CPAP) treatment alleviates the risk of CVD in subjects with OSA. Vascular e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b366d9c8b2a1dca8f0f7143c3e27410c
https://doi.org/10.1007/s11325-018-1660-4
https://doi.org/10.1007/s11325-018-1660-4
Autor:
Jian-Jun Xie, Li-Da Chen, Hui-Xue Zeng, Li Lin, Miao-Feng Hu, Qiyin Wu, Jian-Nan Liu, Liang-Ji Zhang
Publikováno v:
The clinical respiratory journal. 12(2)
Background: Previous studies have suggested that obstructive sleep apnea (OSA) was associated with nonalcoholic fatty liver disease (NAFLD). However, the impact of OSA treatment using continuous positive airway pressure (CPAP) on liver enzymes remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::654dbc2816bcc08b5d8476fe4b55bd21
https://pubmed.ncbi.nlm.nih.gov/27614004
https://pubmed.ncbi.nlm.nih.gov/27614004